Afya Limited (NASDAQ:AFYA) Stock Has Average Target Price of $17.25

Key Points

• Analyst sentiment is neutral: Seven analysts give Afya a consensus “Hold” rating, with five holds and two buys. The average 12-month price target is $17.25.
• Afya recently outperformed earnings expectations: The company reported quarterly EPS of $0.43 versus the $0.40 consensus estimate, while revenue of $187.8 million fell slightly short of expectations.
• Ownership and insider activity were mixed: Institutional investors own 88.02% of the stock, including a new 21,882-share position from Engineers Gate Manager LP, while insider Santos Welder Ferreira sold 4,161 shares at $13.30 each.

Shares of Afya Limited (NASDAQ:AFYA - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven analysts that are presently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $17.25.

Several research firms have recently issued reports on AFYA. JPMorgan Chase & Co. upgraded shares of Afya from a "neutral" rating to an "overweight" rating and decreased their price objective for the company from $21.00 to $19.00 in a report on Wednesday, October 7th. Weiss Ratings lowered shares of Afya from a "hold (c)" rating to a "hold (c-)" rating in a research note on Friday, July 31st. Wall Street Zen raised Afya from a "hold" rating to a "buy" rating in a report on Saturday, September 5th. Bradesco Corretora raised Afya to an "outperform" rating and set a $17.00 target price on the stock in a report on Thursday, September 24th. Finally, Zacks Research upgraded Afya from a "strong sell" rating to a "hold" rating in a research report on Monday, October 5th.

Insider Activity

In other news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction on Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the transaction, the insider directly owned 35,000 shares in the company, valued at approximately $465,500. This trade represents a 10.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Institutional Trading of Afya

A hedge fund recently bought a new stake in Afya stock. Engineers Gate Manager LP acquired a new stake in Afya Limited (NASDAQ:AFYA - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 21,882 shares of the company's stock, valued at approximately $325,000. 88.02% of the stock is currently owned by institutional investors.

Afya Stock Performance

AFYA stock opened at $14.94 on Tuesday. The company has a market capitalization of $1.40 billion, a P/E ratio of 9.11, a PEG ratio of 1.76 and a beta of 0.34. The company has a 50-day simple moving average of $13.87 and a 200 day simple moving average of $14.23. Afya has a fifty-two week low of $11.62 and a fifty-two week high of $16.16. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.39.

Afya (NASDAQ:AFYA - Get Free Report) last released its earnings results on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. Afya had a net margin of 20.55% and a return on equity of 17.58%. The firm had revenue of $187.80 million for the quarter, compared to analysts' expectations of $189.62 million. Sell-side analysts predict that Afya will post 1.72 earnings per share for the current fiscal year.

Afya Company Profile

Afya Limited NASDAQ: AFYA is a Brazil-based medical education and health technology company. The company provides education and professional development for physicians and other healthcare professionals, with activities spanning undergraduate medical programs, medical residency preparation, specialization courses, continuing medical education and digital learning services.

Afya also develops technology-enabled products designed to support healthcare professionals throughout their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.